Clinical Trials Arena July 4, 2025
The move helps in expediting the enrolment process for central nervous system, vaccine, as well as specialty trials.
Headlands Research has acquired Puerto Rico’s clinical research site, CMRCenter (CMRC), for an undisclosed sum.
This strategic move broadens Headlands’ reach to 22 locations covering Canada, the US, and Puerto Rico, and provides biopharma sponsors with a streamlined approach to the Hispanic patient populations regulated by the Food and Drug Administration (FDA).
It also helps in expediting the enrolment process for central nervous system (CNS), vaccine, as well as specialty trials.
Founded and spearheaded by CEO Carmen Navarro, CMRC is backed by its team of investigators, including Dr Carmen Deseda, and joins clinical expertise with public health knowledge.
With a database of...
Today's Sponsors
Today's Sponsor